Bioinvent International AB (0H22) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

BioInvent International is a Swedish clinical-stage biopharmaceutical company that discovers and develops novel antibody-based cancer immunotherapies.

BioInvent share price is listed in London under the ticker 0H22.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings